Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-16

Clinical Trial Update: Salsalate in Patients Mild to Moderate Alzheimer's Disease [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Salsalate in patients with mild-to-moderate Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salsalate (Salsalate)

Snippet

Sponsor: Adam Boxer | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED